# Allogeneic CART-33 for Relapsed/Refractory CD33+ AML

> **NCT02799680** · PHASE1 · UNKNOWN · sponsor: **The Affiliated Hospital of the Chinese Academy of Military Medical Sciences** · enrollment: 12 (estimated)

## Conditions studied

- Relapsed and/or Refractory CD33+ AML

## Interventions

- **BIOLOGICAL:** allogeneic CART-33

## Key facts

- **NCT ID:** NCT02799680
- **Lead sponsor:** The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2017-05
- **Final completion:** 2018-05
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2016-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02799680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02799680, "Allogeneic CART-33 for Relapsed/Refractory CD33+ AML". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02799680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*